Direxion Daily S&P Biotech Bull 3X ETF (LABU)
NYSEARCA: LABU · Real-Time Price · USD
250.41
+0.01 (0.00%)
Sep 16, 2026, 4:00 PM EDT - Market closed
LABU Holdings Information
LABU is an equity ETF with a total of 177 individual holdings. The top holdings are Spsibi Swap Asset Leg stock at 78.31%, Goldman Finl Sq Trsry Inst 506 at 4.41%, Dreyfus Govt Cash Man Ins at 2.84%, Goldman Sachs Fin Gov 465 Institut at 1.09%, and Moderna at 0.81%.
Total Holdings
177
Top 10 Percentage
86.65%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
516.53M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | Spsibi Swap Asset Leg | 21.24% |
| 2 | n/a | Spsibi Swap Asset Leg | 20.35% |
| 3 | n/a | Spsibi Swap Asset Leg | 19.34% |
| 4 | n/a | Spsibi Swap Asset Leg | 13.02% |
| 5 | n/a | Goldman Finl Sq Trsry Inst 506 | 4.41% |
| 6 | n/a | Dreyfus Govt Cash Man Ins | 2.84% |
| 7 | n/a | Spsibi Swap Asset Leg | 1.76% |
| 8 | n/a | Spsibi Swap Asset Leg | 1.45% |
| 9 | n/a | Spsibi Swap Asset Leg | 1.15% |
| 10 | n/a | Goldman Sachs Fin Gov 465 Institut | 1.09% |
| 11 | MRNA | Moderna, Inc. | 0.81% |
| 12 | TWST | Twist Bioscience Corporation | 0.51% |
| 13 | n/a | Cash | 0.49% |
| 14 | NTRA | Natera, Inc. | 0.40% |
| 15 | HALO | Halozyme Therapeutics, Inc. | 0.39% |
| 16 | ORKA | Oruka Therapeutics, Inc. | 0.38% |
| 17 | KYMR | Kymera Therapeutics, Inc. | 0.37% |
| 18 | ROIV | Roivant Sciences Ltd. | 0.37% |
| 19 | RVMD | Revolution Medicines, Inc. | 0.36% |
| 20 | DNTH | Dianthus Therapeutics, Inc. | 0.36% |
| 21 | TVTX | Travere Therapeutics, Inc. | 0.36% |
| 22 | PTGX | Protagonist Therapeutics, Inc. | 0.36% |
| 23 | SMMT | Summit Therapeutics Inc. | 0.35% |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 0.35% |
| 25 | INSM | Insmed Incorporated | 0.35% |
As of Sep 14, 2026